| Aug 28 |
Pliant Therapeutics to Participate in Upcoming Investor Events
|
| Aug 28 |
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
|
| Aug 26 |
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024
|
| Aug 7 |
Pliant Therapeutics GAAP EPS of -$0.92 misses by $0.07
|
| Aug 7 |
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
|
| Aug 6 |
Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
|
| Jul 15 |
Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Continued Antifibrotic and Anti-Cholestatic Activity Displayed Across Multiple Measures
|
| Jun 24 |
7 Biotech Stocks to Buy on the Dip: June 2024
|
| Jun 13 |
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
|
| Jun 12 |
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
